ZELSUVMI

This brand name is authorized in United States.

Active ingredients

The drug ZELSUVMI contains one active pharmaceutical ingredient (API):

1	Berdazimer UNII ORT9SID4QY - BERDAZIMER SODIUM
	Berdazimer is a nitric oxide releasing agent indicated for the topical treatment of molluscum contagiosum. The mechanism of action for the treatment of molluscum contagiosum is unknown.
	Read more about Berdazimer

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
ZELSUVMI Topical gel	MPI, US: SPL/PLR	FDA, National Drug Code (US)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
D06BB13		D Dermatologicals → D06 Antibiotics and chemotherapeutics for dermatological use → D06B Chemotherapeutics for topical use → D06BB Antivirals
Discover more medicines within D06BB13

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
US	FDA, National Drug Code	71403-103